Fast-acting antidepressants: Are we nearly there?

Expert Review of Neurotherapeutics

Volumn 8, Issue 1, 2008, Pages 1-3

  Lucas, Guillaume ^a  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN; SEROTONIN 4 AGONIST; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL RESEARCH; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; POPULATION RESEARCH; PREVALENCE;

EID: 38149067557     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.8.1.1     Document Type: Editorial

References (9)

1. Duman RS. A silver bullet for the treatment of depression? Neuron 55(5), 679-681 (2007).
2. 1A receptors in this context.
3. Szabo ST, Blier P. Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus. Neuropsychopharmacology 25, 845-857 (2001).
4. 1A receptors in the morphological and behavioral effects of antidepressants.
5. Carlezon WA Jr, Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci. 28(8), 436-445 (2005). • Summarizes numerous articles showing the importance of CREB activation in the effect of antidepressants.
6. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20, 9104-9110 (2000). • First complete demonstration of the proneurogenetic action of antidepressants within the mammal hippocampus.
7. Scharfman HE, Hen R. Neuroscience. Is more neurogenesis always better? Science 315, 336-338 (2007).
8. 4 receptor agonists can induce the same molecular, morphological and behavioral changes as 2-3 weeks of treatment with an selective serotonin reuptake inhibitor.
9. Bermack JE, Debonnel G. Modulation of serotonergic neurotransmission by short-and long-term treatments with sigma ligands. Br. J. Pharmacol. 134, 691-699 (2001).